Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Stopped early · Phase 2

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV ovarian epithelial cancer.

Key facts

Study ID
NCT00003386
Run by
Gynecologic Oncology Group
Starts
1999-07-01
Last updated by the study team
2013-04-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.